日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Genome-wide CRISPR-Cas9 screening identifies CLK1 inhibition as a strategy to restore PARP inhibitor sensitivity via ERCC1 isoform switching

全基因组 CRISPR-Cas9 筛选发现,抑制 CLK1 可通过 ERCC1 亚型转换恢复 PARP 抑制剂敏感性。

Liu, Chaohua; Xu, Fei; Wu, Yutuan; Li, Jiana; Ni, Mengdong; Xia, Siyu; Chen, Lihua; Zhao, Haiyun; Yu, Min; Zhou, Yuqi; Zhang, Meiqin; Li, Jiajia; Wu, Xiaohua; Huang, Yan; Zhu, Tao; Chen, Xiaojun

Immunometabolic Reprogramming in Experimental Sepsis: A Driver of Multiple Organ Dysfunction Syndrome

实验性脓毒症中的免疫代谢重编程:多器官功能障碍综合征的驱动因素

Wu, Fan; Chen, Yantong; Chen, Lihua; Wei, Xiaolu; Zhang, Lin; Shen, Yi

Charge-convertible MnO(2)-coated liposomal nanocarriers boost doxorubicin delivery for potentiated breast cancer chemotherapy.

电荷可转换的 MnO(2) 包覆脂质体纳米载体可增强阿霉素的递送,从而提高乳腺癌化疗的疗效。

He Chuanchuan, Kong Shuaizhi, Zhang Jie, Chen Lihua, Zhang Guoqing, Jin Limin, Zhang Xiaojuan, Ding Baoyue

Impact of nonpharmaceutical interventions on infectious disease patterns in Yunnan Province across the COVID-19 pandemic phases

非药物干预措施对云南省新冠肺炎疫情各阶段传染病模式的影响

Chen, Lihua; Gao, Huxing; Zhang, Jiarui; Xu, Chuanzhi; Lu, Shuiping; Pan, Yue; Thilakavathy, Karuppiah; Zhao, Shiwen; Xiong, Chenglong; Sun, Zhong

Carbapenem-resistant Gram-negative bacteremia in a medical intensive care unit: predictors, antimicrobial susceptibilities, and its effects on mortality

内科重症监护病房中耐碳青霉烯类革兰氏阴性菌血症:预测因素、抗菌药物敏感性及其对死亡率的影响

Long, Guo; Chen, Lihua; Li, Yuanming

Spatiotemporal Epidemiological Characteristics of Dengue Fever and Its Relationship with Meteorological Factors - Yunnan Province, China, 2012-2024

2012-2024年中国云南省登革热时空流行病学特征及其与气象因素的关系

Chen, Lihua; Shao, Heng; Li, Dan; Ren, Ruiqi; Bai, Wenqing; He, Jibo; Cao, Yihui; Li, Chao

iMeta Conference 2025: Creating high-impact international journals

2025年iMeta会议:创建高影响力国际期刊

Zhu, Zhihao; Zhang, Lin; Yao, Xiaofang; Zeng, Meiyin; Wang, Yao; Luo, Hao; Zhou, Yuanping; Zhang, Tianyuan; Xun, Jiani; Bai, Defeng; Yang, Haifei; Xu, Shanshan; Zhou, Yang; Gao, Yunyun; Xu, Jinbo; Han, Wei; Shen, ZiAng; Zhang, Bangzhou; Ma, Tengfei; Wan, Xiu-Lin; Ma, Chuang; Hui, Fengjiao; Bai, Hao; Bai, Lijing; Bai, Qing; Bao, Qiangguo; Cao, Guodong; Cao, Peng; Cao, Qiqi; Chen, Hu; Chen, Jiawen; Chen, Jiaxu; Chen, Lihua; Chen, Tingting; Chen, Yi; Cui, Haipeng; Dai, Shaoxing; Dai, Xi-Jian; Dai, Xiaofeng; Dang, Yanqi; Deng, Lei; Deng, Yun; Ding, Xia; Dong, Binhua; Dong, Ling; Dou, Shujie; Du, Hongzhi; Fang, Zhencheng; Feng, Xiaoxiao; Fu, Min; Gao, Yuan; Gong, Wenping; Guo, Xiang; Han, Wenjie; Hao, Zikai; He, Zheng-Guo; Hu, Haibo; Hu, Haiming; Hu, Xuefei; Huang, Liang; Huang, Xianya; Huang, Xueting; Hui, Haochen; Jia, Dingjiacheng; Jiang, Aimin; Jiang, Di; Jiang, Kun; Jiang, Dewei; Jin, Ying; Lai, Kunyang; Li, Chun; Li, Feng; Li, Fuyong; Li, Jing; Li, Juan; Li, Junling; Li, Kui; Li, Ling; Li, Moli; Li, Peiwu; Li, Peng; Li, Runze; Li, Shengnan; Li, Shujin; Li, Wanting; Li, Wenting; Li, Xiaojing; Li, Xinrui; Li, Xuemeng; Liang, Qiqi; Liao, Xiaoping; Liu, Boyang; Liu, Canzhao; Liu, Chang; Liu, Duanrui; Liu, Furong; Liu, Jianjun; Liu, Jinyao; Liu, Siqi; Liu, Tianyang; Liu, Wenjuan; Liu, Yan; Liu, Yang; Liu, Yi; Liu, Yuan; Liu, Yunhuan; Liu, Zhipeng; Liu, Zhiyong; Lu, Xin; Luo, Xiao; Ma, Guanju; Meng, Jialin; Meng, Yuanfa; Miao, Runyu; Miao, Linxuan; Ni, Yawen; Niu, Dongze; Niu, Tingting; Pan, Hongzhao; Qin, Guoqiang; Qiu, Tiantian; Qiu, Yueping; Qu, Hui; Qu, Linghang; Ren, Na; Sun, Qiang; Shang, Run; She, Peize; Shen, Xihui; Shi, Bohan; Shu, You; Song, Jiawei; Song, Weibin; Su, Qi; Sun, Qingzhu; Sun, YuPing; Sun, Zijin; Tang, Bufu; Tang, Deqin; Tang, Hua; Tao, Yongfu; Teng, Teng; Tu, Yanye; Wang, Cheng; Wang, Hui; Wang, Yunhao; Wang, Chunli; Wang, Dingjie; Wang, Gang; Wang, Jin; Wang, Kaiyi; Wang, Mingbang; Wang, Shan; Wang, Shixiang; Wang, Xiaojie; Wang, Xing-Chang; Wang, Yunzhe; Wang, Jiale; Wang, Zheng; Wang, Weijie; Wei, Yongjun; Xu, Wei; Wu, Fan; Wu, Junling; Wu, Shijuan; Xiao, Jian; Xiao, Weihua; Xiao, Yang; Xiong, Xi; Xiong, Xue; Xu, Feng; Xu, Junyu; Xu, Wen; Xu, Jun; Xu, Yao; Yan, Jun; Yao, Lutian; Yang, Jia; Yang, Lulu; Yang, Xingzhen; Yin, Naiyi; You, Hua; You, Min; Yu, Ting; Yu, Yongyao; Yu, Renqiang; Yuan, Shuofeng; Yue, Chaoxiong; Zeng, Xiaoya; Zha, Andong; Zhai, Leilei; Zhang, Chi; Zhang, Dong; Zhang, Hengguo; Zhang, Heng; Zhang, Hongyu; Zhang, Jiahao; Zhang, Jinyang; Zhang, Lishan; Zhang, Qi; Zhang, Xiang; Zhang, Xiangyu; Zhang, Xuelei; Zhang, Yancong; Zhang, Yuan; Zhang, Zhenyu; Zhao, Jiwei; Zhao, Jingxuan; Zhao, Kai; Zhao, Mingjuan; Zhao, Yi; Zhao, Yunxiang; Zhong, Jixin; Zhong, Ling; Zhong, Xiangjian; Zhou, Dan; Zhou, Wei; Zhou, Wen; Zhou, Yiqian; Zhou, Zhemin; Zhu, Shiquan; Liu, Shuang-Jiang; Feng, Suyin; Jin, Shuangxia; Xiao, Chuanxing; Wang, Ziheng; Luo, Peng; Chen, Tong; Chen, Gang; Liu, Yong-Xin

Restoration of PKM1 improves functional maturation of human stem-cell derived-β cell by regulating PEP metabolism.

PKM1 的恢复通过调节 PEP 代谢改善人类干细胞衍生 β 细胞的功能成熟。

Lin Haopeng, Liu Xin, Zhang Feng, Chen Deqi, Xie Xiaoxiao, Dong Qifei, Yan Jiawei, Yin Jiaxiang, Bi Zirong, Dou Zhihua, Jiang Yingling, Jiang Kuo, Zhang Tongran, Xue Peng, Peng Wei, Chen Lihua, Xu Tao, Li Zonghong, Guo Yanying, Liu Huisheng

YY1 enhances HIF-1α stability in tumor-associated macrophages to suppress anti-tumor immunity of prostate cancer in mice

YY1通过增强肿瘤相关巨噬细胞中HIF-1α的稳定性来抑制小鼠前列腺癌的抗肿瘤免疫反应。

Wenchao Li #,SaiSai Chen #,Jian Lu #,Weipu Mao #,Shiya Zheng #,Minhao Zhang #,Tiange Wu,Yurui Chen,Kai Lu,Chunyan Chu,Chuanjun Shu,Yue Hou,Xue Yang,Naipeng Shi,Zhijun Chen,Lihua Zhang,Lei Zhang,Rong Na,Ming Chen,Shenghong Ju,Dingxiao Zhang,Yi Ma,Bin Xu

YY1 enhances HIF-1α stability in tumor-associated macrophages to suppress anti-tumor immunity of prostate cancer in mice

YY1通过增强肿瘤相关巨噬细胞中HIF-1α的稳定性来抑制小鼠前列腺癌的抗肿瘤免疫反应。

Wenchao Li # ,SaiSai Chen # ,Jian Lu # ,Weipu Mao # ,Shiya Zheng # ,Minhao Zhang # ,Tiange Wu ,Yurui Chen ,Kai Lu ,Chunyan Chu ,Chuanjun Shu ,Yue Hou ,Xue Yang ,Naipeng Shi ,Zhijun Chen ,Lihua Zhang ,Lei Zhang ,Rong Na ,Ming Chen ,Shenghong Ju ,Dingxiao Zhang ,Yi Ma ,Bin Xu